Lewy body dementia: Overcoming barriers and identifying solutions.

Area of Science:

• Neuroscience
• Neurology
• Public Health

Background:

• Lewy body dementia (LBD) is a prevalent but poorly understood dementia.
• Overlapping pathologies and lack of treatments exacerbate the public health burden of LBD.
• Misdiagnosis is common due to overlapping pathologies.

Purpose of the Study:

• To identify critical gaps in advocacy, funding, research outputs, and therapeutic pipeline for LBD.
• To understand current challenges through expert interviews and data analysis.
• To propose a framework for collaboration to bridge identified gaps.

Main Methods:

• Analysis of public-domain information on LBD advocacy, funding, research, and therapeutics.
• Interviews with experts from regulatory, advocacy, academic, and biopharmaceutical sectors.
• A workshop involving experts to prioritize research areas for LBD.

Main Results:

• Significant gaps identified across all analyzed LBD landscape elements.
• Research gaps are the most critical, hindering therapeutic development.
• Expert consensus identified key priorities for accelerating LBD research and care.

Conclusions:

• Bridging identified gaps requires a collaborative framework.
• Prioritizing research is essential for advancing LBD therapeutic development.
• The white paper outlines opportunities to improve LBD patient care and outcomes.